Last Price$83.1(1.2%)
Market Cap$4,238.0M
P/BV LTM
11.0x
5Y avg
13.2x
Consulting Services industry
median
4.1x
Stock quality & Intrinsic value
7/10
(0.6%) overvalued
Exponent, Inc. P/BV LTM
Annual
Quarterly
Daily
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Jan'14 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Jan'20 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Jan'25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/BV LTM | 2.0x | 2.5x | 3.4x | 3.4x | 2.7x | 3.2x | 3.6x | 3.5x | 4.5x | 4.6x | 5.2x | 6.0x | 6.3x | 7.9x | 10.3x | 13.7x | 15.1x | 16.1x | 12.9x | 11.0x |
Overvalued or undervalued?
Check the intrinsic value for EXPO
and see if it's the right time to invest.
Exponent, Inc. (EXPO) P/BV LTM comparison analysis
General
LTM P/BV LTM
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Exponent, Inc.EXPO
10.1x
4.1%
8.7%
19.5%
Median Peer Set
4.1x
7.0%
17.5%
6.8%
Booz Allen Hamilton Holding CorporationBAH
11.5x
15.2%
126.0%
5.7%
Equifax Inc.EFX
6.2x
7.9%
9.9%
10.6%
CRA International, Inc.CRAI
5.6x
10.2%
25.0%
6.8%
Franklin Covey Co.FC
5.1x
2.4%
36.9%
8.1%
Huron Consulting Group Inc.HURN
4.6x
8.8%
96.4%
7.7%
TransUnionTRU
3.7x
9.2%
N/A
6.8%
FTI Consulting, Inc.FCN
2.6x
6.0%
(1.7%)
7.6%
ICF International, Inc.ICFI
1.7x
2.9%
33.9%
5.5%
Resources Connection, Inc.RGP
0.7x
(18.4%)
(61.3%)
3.3%
Verisk Analytics, Inc.VRSK
(14.8x)
(72.6%)
(99.7%)
0.2%
EXPO key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Jan'09 | Jan'10 | Dec'10 | Dec'11 | Dec'12 | Jan'14 | Jan'15 | Jan'16 | Dec'16 | Dec'17 | Dec'18 | Jan'20 | Jan'21 | Dec'21 | Dec'22 | Dec'23 | Jan'25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 155.2 2.4% | 168.5 8.6% | 205.1 21.8% | 228.8 11.5% | 227.9 (0.4%) | 248.8 9.2% | 272.4 9.5% | 292.7 7.4% | 296.2 1.2% | 304.7 2.9% | 312.8 2.7% | 315.1 0.7% | 347.8 10.4% | 379.5 9.1% | 417.2 9.9% | 399.9 (4.1%) | 466.3 16.6% | 513.3 10.1% | 536.8 4.6% | 558.5 4.1% |
| Cost of Goods Sold (COGS) | 31.0 | 31.6 | 43.7 | 156.1 | 162.3 | 171.7 | 182.6 | 26.1 | 16.1 | 15.5 | 17.1 | 15.9 | 18.1 | 24.9 | 25.8 | 303.8 | 32.6 | 35.1 | 41.5 | 0.0 |
% margin | 124.2 80.1% | 136.9 81.2% | 161.5 78.7% | 72.7 31.8% | 65.6 28.8% | 77.0 31.0% | 89.8 33.0% | 266.6 91.1% | 280.0 94.6% | 289.2 94.9% | 295.7 94.5% | 299.2 95.0% | 329.7 94.8% | 354.6 93.4% | 391.4 93.8% | 96.1 24.0% | 433.7 93.0% | 478.2 93.2% | 495.2 92.3% | 558.5 100.0% |
| Operating Expenses | 103.9 | 116.7 | 131.5 | 192.1 | 194.6 | 33.8 | 36.4 | 235.0 | 240.2 | 241.2 | 243.9 | 253.2 | 275.7 | 288.1 | 332.1 | 316.7 | 357.3 | 372.5 | 383.9 | 439.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 103.9 | 116.7 | 131.5 | 13.4 | 173.3 | 12.4 | 13.1 | 185.4 | 198.8 | 199.4 | 199.8 | 208.9 | 228.1 | 232.6 | 272.7 | 262.9 | 293.3 | 287.9 | 24.4 | 22.7 |
% margin | 20.4 13.1% | 20.2 12.0% | 29.9 14.6% | 36.7 16.0% | 33.3 14.6% | 43.2 17.4% | 53.5 19.6% | 57.6 19.7% | 55.9 18.9% | 63.5 20.9% | 68.9 22.0% | 61.9 19.6% | 72.1 20.7% | 91.5 24.1% | 85.1 20.4% | 83.2 20.8% | 108.9 23.4% | 140.8 27.4% | 111.3 20.7% | 119.6 21.4% |
| Interest Income | 0.0 | 0.0 | 1.8 | 1.7 | 0.0 | 0.2 | 0.2 | 0.3 | 0.1 | 0.2 | 0.2 | 0.7 | 1.3 | 2.8 | 3.9 | 1.7 | 0.1 | 2.1 | 7.2 | 10.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 0.0 | 0.0 |
| Pre-tax Income | 22.6 | 23.6 | 33.6 | 38.5 | 37.0 | 46.7 | 54.8 | 61.7 | 63.9 | 68.0 | 71.1 | 69.1 | 82.5 | 93.3 | 104.2 | 96.9 | 125.8 | 132.2 | 135.9 | 147.4 |
% effective tax rate | 8.4 37.3% | 9.4 39.8% | 13.3 39.5% | 15.3 39.8% | 14.9 40.2% | 19.2 41.1% | 22.1 40.4% | 24.5 39.7% | 25.3 39.6% | 27.3 40.1% | 27.5 38.7% | 21.6 31.3% | 41.2 49.9% | 21.1 22.6% | 21.7 20.9% | 14.4 14.8% | 24.6 19.6% | 29.9 22.6% | 35.6 26.2% | 38.4 26.0% |
% margin | 14.2 9.1% | 14.2 8.4% | 20.3 9.9% | 23.2 10.1% | 22.1 9.7% | 27.5 11.1% | 32.7 12.0% | 37.2 12.7% | 38.6 13.0% | 40.7 13.4% | 43.6 13.9% | 47.5 15.1% | 41.3 11.9% | 72.3 19.0% | 82.5 19.8% | 82.6 20.6% | 101.2 21.7% | 102.3 19.9% | 100.3 18.7% | 109.0 19.5% |
| EPS | 0.22 | 0.22 | 0.34 | 0.39 | 0.39 | 0.48 | 0.58 | 0.68 | 0.71 | 0.76 | 0.82 | 0.90 | 0.78 | 1.37 | 1.57 | 1.58 | 1.92 | 1.98 | 1.96 | 2.13 |
| Diluted EPS | 0.20 | 0.21 | 0.31 | 0.37 | 0.37 | 0.46 | 0.56 | 0.65 | 0.69 | 0.74 | 0.80 | 0.87 | 0.77 | 1.33 | 1.53 | 1.55 | 1.90 | 1.96 | 1.94 | 2.11 |
% margin | 26.1 16.8% | 27.2 16.2% | 37.5 18.3% | 40.8 17.8% | 37.6 16.5% | 47.6 19.1% | 57.9 21.2% | 62.3 21.3% | 60.9 20.6% | 69.0 22.6% | 74.4 23.8% | 68.0 21.6% | 78.3 22.5% | 97.7 25.8% | 91.9 22.0% | 90.1 22.5% | 115.4 24.8% | 147.9 28.8% | 120.2 22.4% | 129.2 23.1% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Exponent, Inc.'s P/BV LTM?
As of today, Microsoft Corp's last 12-month P/BV LTM is 11.0x, based on the financial report for Jan 02, 2025 (Q1’2025). The average annual P/BV LTM for Exponent, Inc. have been 13.6x over the past three years, and 13.9x over the past five years.
2) Is Exponent, Inc.'s P/BV LTM Good?
As of today, Exponent, Inc.'s P/BV LTM is 11.0x, which is higher than industry median of 4.1x. It indicates that Exponent, Inc.'s P/BV LTM is Bad.